Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Manic Episode”

97 trials

Showing 20 of 97 results

Not applicableUnknownNCT05622552
What this trial is testing

Effect of tDCS Combined With Pharmacological Treatments for Bipolar Mania

Who this might be right for
Manic Episode
Dongbin Lyu 70
Not applicableStudy completedNCT00533260
What this trial is testing

A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)

Who this might be right for
Bipolar DisorderSchizophrenia
AstraZeneca 128
Large-scale testing (Phase 3)Study completedNCT03573297
What this trial is testing

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Who this might be right for
Bipolar I DisorderManiaDepression
AbbVie 901
Large-scale testing (Phase 3)Study completedNCT01602510
What this trial is testing

Lamotrigine Phase III Study in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
GlaxoSmithKline 265
Large-scale testing (Phase 3)Study completedNCT00266630
What this trial is testing

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Who this might be right for
Manic or Mixed Episode Associated With Bipolar I Disorder
Eli Lilly and Company 139
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Large-scale testing (Phase 3)Study completedNCT04819776
What this trial is testing

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Vanda Pharmaceuticals 417
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Post-approval studies (Phase 4)Study completedNCT00982020
What this trial is testing

Study in Adolescents With Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar I DisorderSchizophrenia
Eli Lilly and Company 203
Not applicableStudy completedNCT00538629
What this trial is testing

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Who this might be right for
Bipolar DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 471
Large-scale testing (Phase 3)Study completedNCT00159796
What this trial is testing

3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

Who this might be right for
Bipolar Disorder
Organon and Co 489
Post-approval studies (Phase 4)Study completedNCT00264173
What this trial is testing

VALID : VAlproate Versus LIthium in Bipolar Disorders

Who this might be right for
Bipolar Disorder
Sanofi 270
Large-scale testing (Phase 3)Study completedNCT00037674
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 434
Large-scale testing (Phase 3)Study completedNCT01244815
What this trial is testing

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

Who this might be right for
Bipolar Disorder, Pediatric
Organon and Co 404
Large-scale testing (Phase 3)Study completedNCT00490971
What this trial is testing

Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Large-scale testing (Phase 3)Looking for participantsNCT06462612
What this trial is testing

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 350
Large-scale testing (Phase 3)Study completedNCT01977300
What this trial is testing

Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode

Who this might be right for
Bipolar I Disorder
University of British Columbia 159
Large-scale testing (Phase 3)Looking for participantsNCT06951698
What this trial is testing

Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

Who this might be right for
Bipolar-I Disorder With Mania or Mania With Mixed Features
Bristol-Myers Squibb 274
Large-scale testing (Phase 3)Study completedNCT03259555
What this trial is testing

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I DisorderManic Episode
Otsuka Pharmaceutical Development & Commercialization, Inc. 322
Large-scale testing (Phase 3)Ended earlyNCT03768726
What this trial is testing

Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 23
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation